Coagulation function in patients with pancreatic carcinoma

Chinese Medical Journal

Volumn 122, Issue 6, 2009, Pages 697-700

  Wang, Hang Yan ^a   Xiu, Dian Rong ^a   Li, Zhi Fei ^a   Wang, Gang ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Fibrinogen; Pancreatic cancer; Pancreatic carcinoma; Vitamin K

Indexed keywords

FIBRINOGEN; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; BILE DUCT STONE; BLEEDING; BLOOD CLOTTING; CANCER INVASION; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; JAUNDICE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDY; CHOLELITHIASIS; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; CHOLELITHIASIS; FEMALE; FIBRINOGEN; HUMANS; JAUNDICE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; VITAMIN K; YOUNG ADULT;

EID: 67649786620     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.06.020     Document Type: Article

References (23)

1. Tomimaru Y, Yano M, Takachi K, Kishi K, Miyashiro I, Ohue M, et al. Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer. J Am Coll Surg 2006; 202: 139-145.
2. Yamashita H, Kitayama J, Kanno N, Yatomi Y, Nagawa H. Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 2006; 6: 147.
3. Gadducci A, Baicchi U, Marrai R, Facchini V, del-Bravo B, Fosella PV, et al. Pretreatment plasma levels of and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol 1993; 49: 354-358.
4. Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer 2002; 86: 389-395.
5. Lee JH, Ryu KW, Kim S, Bae JM. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology 2004; 51: 1860-1863.
6. Roche Y, Pasquier D, Rambeaud JJ, Seigneurin D, Duperray A. Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway. Thromb Haemost 2003; 89: 1089-1097.
7. Marx R. The therapeutic effects of natural vitamin K1, in decreasing the potential of serum steady thrombokinase factors in cases of obstructive jaundice and of liver cirrhosis. Med Monatsschr 1955; 9: 371-373.
8. Mossberg HO. Vitamin K in the treatment of acute hepatitis. Br Med J 1952; 1: 1382-1384.
9. Bick RL, Strauss JF, Frenkel EP. Thrombosis and hemorrhage in oncology patients. Hematol Oncol Clin North Am 1996; 10: 875-908.
10. Kakkar AK, Lemoine NR, Stone SR, Altieri D, Williamson RC. Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells. J Clin Pathol 1995; 48: M288-M290.
11. Palumbo JS, Degen JL. Fibrinogen and tumor cell metastasis. Haemostasis 2001; 31 Suppl 1: 11-15.
12. Wojtukiewicz MZ, Rucinska M, Zacharski LR, Kozlowski L, Zimnoch L, Piotrowski Z, et al. Localization of blood coagulation factors in situ in pancreatic carcinoma. Thromb Haemost 2001; 86: 1416-1420.
13. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 2002; 62: 6966-6972.
14. Dong P, Shen DF, Yang Y, Zhang Y. Study of coagulation alternation in patients with gastric cancer. Chin J Gen Surg (Chin) 2004; 13: 654-657.
15. Wu ZY, Qi J, Zhao GH, Jia DQ, Zhang ZJ, Mu JJ, et al. Clinical significance of plasma fibrinogen and D-dimer test in liver carcinoma. Labeled Immun Clin Med (Chin) 2006; 13: 68-69.
16. Haas SL, Jesnowski R, Steiner M, Hummel F, Ringel J, Burstein C, et al. Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol 2006; 12: 4843-4849.
17. Levine MN, Lee AY. Treatment of venous thrombosis in the cancer patient. Acta Haematol 2001; 106: 81-87.
18. Lee AY, Levine MN. Management of venous thromboembolism in cancer patients. Oncology 2000; 14: 409-417.
19. Monreal M. Long-term treatment of venous thromboembolism with low-molecular-weight heparin. Curr Opin Pulm Med 2006; 4: 326-329.
20. Schulman S. Venous thromboembolism, warfarin and cancer-a well-known connection. Lakartidningen 2000; 97: 4554.
21. He TL, Cao GS, Zhou YQ, Hu XG. Clinical comparative study on hypercoagulation in patients with gastric cancer or pancreatic cancer after operation. Chin J Gen Surg (Chin) 2004; 11: 226-229.
22. Palumbo JS, Degen JL. Hemostatic factors in tumor biology. J Pediatr Hemato Oncol 2000; 22: 281-287.
23. Gieseler F, Luhr I, Kunze T, Mundhenke C, Maass N, Erhart T, et al. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Thromb Haemost 2007; 97: 1023-1030.